BHC R&D to Revenue
Bausch Health Companies Inc. Common Stock · R&D to Revenue
BHC R&D to Revenue
Latest reported6.13%period ending
BHC FY R&D/Revenue (0.00% → 6.13%)
Latest values, visible window
High-resolution chart · PNG
BHC r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 6.127% | |
| 6.587% | |
| 6.8973% | |
| 6.5239% | |
| 5.6083% | |
| 6.0421% | |
| 5.9993% | |
| 5.2745% | |
| 4.2297% | |
| 4.848% | |
| 4.2138% | |
| 3.2439% | |
| 2.7196% | |
| 2.2727% | |
| 7.0993% | |
| 13.7468% | |
| 1.7245% | |
| 12.2618% | |
| 14.0145% | |
| 8.9188% | |
| 9.5009% | |
| 8.1778% | |
| 10.5096% | |
| 6.6178% | |
| 8.7468% | |
| 17.0324% | |
| 18.7535% | |
| 15.5142% | |
| 0% | |
| 11.2952% | |
| 0% | |
| 0% | |
| 0% |